SynthesisGlobal journal of health science2015

Health Economics and Radium-223 (Xofigo®) in the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Case History and a Systematic Review of the Literature.

Jan Norum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.